| ID | 2155 |
|---|
| No | 2155 |
|---|
| Brand Name | AUROBRIME |
|---|
| Ingredients | BRIMONIDINE TARTRATE 0.2% W/V EQ.TO BRIMONIDINE BASE 0.13 % W/V |
|---|
| Dosage Form | EYE DROPS |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 5 ML/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION. AS MONOTHERAPY IN PATIENTS IN WHOM TOPICAL BETA-BLOCKER THERAPY IS CONTRA-INDICATED. AS ADJUNCTIVE THERAPY TO OTHER INTRAOCULAR PREESURE LOWERING MEDICATIONS WHEN THE TARGET INTRAOCULAR PRESSURE IS NOT ACHIEVED WITH A SINGLE AGENT. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | CLEAR, PALE YELLOW COLOR AQUEOUS SOLUTION. |
|---|
| Note | |
|---|
| License Owner | POUNSAB PHARMA CO.,LTD |
|---|
| Manufacturer | AUROLAB |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 10 I 5303/22 |
|---|
| FDD Registration Date | 11/11/2022 |
|---|
| Expiry Date | 10/11/2025 |
|---|
